Search Results 271-280 of 17241 for GLP-1 therapy

1. Psoriatic arthritis - Diagnosis & treatment - Mayo Clinic

   One of the main treatment options is prescription medicine called disease-modifying antirheumatic drugs, often shortened to DMARDs. Your treatment plan will ...

2. First FDA-approved retinal gene therapy available at Mayo Clinic

   The first prescription retinal gene therapy product is now available at Mayo Clinic. For eligible patients, voretigene neparvovec-rzyl is a one-time gene ...

3. Dr. Adrian Vella Archives - Mayo Clinic News Network

   treating Type 2 diabetes. The group advises clinicians to prescribe metformin to patients with Type 2 diabetes as first-line therapy. Then adding to the ...

4. A Comparative Effectiveness Study Of Major Glycemia-lowering Medications For Treatment Of Type 2 Diabetes - Mayo Clinic

   ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.

5. Study Of NRTX-1001 Neural Cell Therapy In Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy)) - Mayo Clinic

   ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.

6. Cellular Therapy Clinical Trials - Mayo Clinic Research

   The purpose of this study is to assess the safety and tolerability of intra-arterially delivered mesenchymal stem/stromal cells (MSC) to a single kidney in one ...

7. Medical Research & Education - Mayo Clinic News Network

   ... GLP-1s. Latest stories. Mayo Clinic Proceedings, Kidney International publish ... Preparing to biomanufacture a new CAR-T cell therapy for B-cell cancers featured.

8. Combination of Serabelisib and Insulin Suppressing Diet in Subjects With Advanced Solid Tumors with PIK3CA Mutations - Mayo Clinic

   For monoclonal antibody therapy, the subject is < 1 half-life or <4 weeks from the last dose. 7. Chronic, systemically administered glucocorticoids in doses ...

9. Neurosurgery - Clinical trials

   ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

10. A Study to Assess Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) - Mayo Clinic

    Subjects in this study will receive one of four intramyocardial doses of XC001 that expresses human vascular endothelial growth factor (VEGF) which induces ...